Sanjeev Sethi Selected Research

Lipoid Nephrosis (Glomerulonephritis, Minimal Change)

10/2021	Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
4/2014	Frequent-relapsing, steroid-dependent minimal change disease: is rituximab the answer?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjeev Sethi Research Topics

Disease

49	Glomerulonephritis 05/2024 - 08/2003
39	Proteinuria 03/2023 - 02/2006
35	Membranous Glomerulonephritis (Membranous Nephropathy) 02/2024 - 05/2008
28	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 03/2024 - 09/2004
26	Amyloidosis 09/2023 - 12/2010
20	Paraproteinemias (Monoclonal Gammopathy) 03/2023 - 11/2010
15	Chronic Kidney Failure (Chronic Renal Failure) 05/2024 - 06/2010
11	Renal Insufficiency (Renal Failure) 01/2022 - 05/2005
10	Kidney Diseases (Kidney Disease) 05/2024 - 12/2012
10	Infections 01/2022 - 12/2012
9	Vasculitis (Vasculitides) 05/2024 - 03/2010
9	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2024 - 09/2011
9	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 05/2008
9	Thrombotic Microangiopathies 01/2021 - 02/2006
9	Atypical Hemolytic Uremic Syndrome 01/2021 - 06/2014
9	Hematuria 01/2020 - 08/2010
8	Amyloid Plaque 01/2022 - 07/2012
8	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 01/2004
8	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019 - 07/2011
7	Fibrosis (Cirrhosis) 02/2024 - 04/2008
7	Neoplasms (Cancer) 01/2023 - 05/2011
6	Atrophy 02/2024 - 04/2008
6	Acute Kidney Injury (Acute Renal Failure) 03/2021 - 11/2010
5	Microscopic Polyangiitis 05/2024 - 09/2009
5	Lupus Nephritis 01/2022 - 10/2012
5	Multiple Myeloma 03/2021 - 11/2010
4	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 05/2024 - 05/2011
4	Inflammation (Inflammations) 02/2024 - 02/2013
4	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2022 - 04/2008
4	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 01/2022 - 04/2007
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 09/2013
3	Nephritis 09/2023 - 07/2014
3	Familial Amyloidosis (Hereditary Amyloidosis) 02/2017 - 07/2011
3	Chronic Renal Insufficiency 01/2017 - 01/2012
3	Monoclonal Gammopathy of Undetermined Significance 11/2013 - 11/2010
3	Diabetic Nephropathies (Diabetic Nephropathy) 06/2012 - 01/2011
2	Rare Diseases (Rare Disease) 03/2024 - 09/2007
2	Disease Progression 02/2024 - 12/2015
2	Hepatitis B 01/2023 - 07/2011
2	Arteriosclerosis 10/2022 - 06/2012
2	Pathologic Constriction (Stenosis) 10/2022 - 04/2008
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2021 - 01/2019
2	COVID-19 10/2021 - 04/2021
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 10/2021 - 04/2014
2	Malignant Hypertension 01/2021 - 02/2006

Drug/Important Bio-Agent (IBA)

36	Complement System Proteins (Complement)IBA 03/2024 - 05/2009
28	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 01/2002
27	CreatinineIBA 03/2023 - 06/2010
25	Antigen-Antibody Complex (Immune Complex)IBA 03/2024 - 05/2009
23	Proteins (Proteins, Gene)FDA Link 03/2023 - 12/2010
21	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2024 - 08/2003
17	AntigensIBA 02/2024 - 03/2012
14	Amyloid (Amyloid Fibrils)IBA 10/2020 - 11/2010
13	Dichlorodiphenyldichloroethane (DDD)IBA 03/2024 - 09/2007
12	Immunoglobulin G (IgG)IBA 01/2023 - 04/2007
12	Rituximab (Mabthera)FDA Link 11/2020 - 09/2007
9	Congo RedIBA 01/2022 - 07/2011
8	AntibodiesIBA 12/2021 - 09/2009
7	AutoantibodiesIBA 05/2024 - 07/2011
6	ApolipoproteinsIBA 03/2024 - 01/2013
6	Prednisone (Sone)FDA LinkGeneric 01/2022 - 05/2011
6	AA amyloidosisIBA 10/2019 - 06/2011
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2017 - 05/2011
5	Peroxidase (Myeloperoxidase)IBA 05/2024 - 09/2009
5	Phospholipase A2 ReceptorsIBA 06/2023 - 03/2012
5	GelsolinIBA 01/2018 - 01/2012
5	Chemotactic FactorsIBA 02/2017 - 09/2013
4	SteroidsIBA 01/2019 - 08/2011
4	eculizumab FDA Link 01/2019 - 09/2007
4	Complement Factor H (Factor H)IBA 10/2018 - 07/2012
4	Amyloidogenic ProteinsIBA 01/2018 - 05/2013
4	Fibrinogen (Factor I)FDA Link 01/2018 - 01/2012
4	Bortezomib (Velcade)FDA Link 07/2015 - 09/2013
4	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2013 - 07/2011
3	Myeloblastin (Proteinase 3)IBA 05/2024 - 08/2003
3	antiglomerular basement membrane antibodyIBA 09/2023 - 07/2014
3	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2013
3	CryoglobulinsIBA 01/2022 - 02/2017
3	Complement C3 (C3 Complement)IBA 01/2022 - 06/2014
3	Immunoglobulin A (IgA)IBA 03/2021 - 05/2015
3	ParaffinIBA 01/2020 - 07/2014
3	ThrombospondinsIBA 01/2019 - 02/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 09/2013
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 03/2010
3	Serum Amyloid P-ComponentIBA 01/2018 - 01/2013
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2013 - 01/2012
2	Epidermal Growth Factor (EGF)IBA 03/2023 - 01/2020
2	ReninIBA 10/2022 - 01/2019
2	CollagenIBA 10/2022 - 04/2009
2	Semaphorins (Semaphorin)IBA 01/2021 - 11/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2003
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 01/2015
2	AngiotensinsIBA 01/2019 - 01/2019

Therapy/Procedure

16	Therapeutics 01/2023 - 08/2003
16	Lasers (Laser) 11/2020 - 12/2010
9	Drug Therapy (Chemotherapy) 03/2021 - 09/2004
4	Kidney Transplantation 09/2023 - 04/2008
3	Plasma Exchange 01/2022 - 07/2006
3	Renal Dialysis (Hemodialysis) 01/2019 - 04/2016
2	Transplantation 01/2021 - 03/2013